Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2025-12-25 @ 9:42 PM
Study NCT ID:
NCT06415851
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-05-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab
Sponsor:
Zhangfa Song
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-03
First Submit QC Date:
None
Study First Post Date:
2024-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-14
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL